ESR1 and breast cancer: One plausible explanation is that estrogen receptor alpha (ERα), which is present in MCF7 but not in MDA-MB-231 cells, modulates FOXM1 activity by recruiting FOXM1 to ERα binding sites [59, 60] and causing differential FOXM1 binding between the two breast-cancer cell lines [59].